Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Atomoxetine To Enhance COgnition In Patients With Schizophrenia

NCT00488163 is registered in ClinicalTrials.gov with Research Foundation for Mental Hygiene, Inc. as lead sponsor.

NCT NCT00488163
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00488163 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Atomoxetine To Enhance COgnition In Patients With Schizophrenia
Lead sponsor
Research Foundation for Mental Hygiene, Inc.
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2005
Completion date
June 30, 2007
Enrollment
20 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia